1786a. Group Leader
Session: Poster Discussion Round: Clostridium difficile
Saturday, October 5, 2013: 12:30 PM
Room: The Moscone Center: Poster Hall C
Dale Gerding, MD, FIDSA, Hines Veterans Affairs Hospital and Loyola University Stritch School of Medicine, Hines, IL

Dale N. Gerding, MD
Dr. Gerding is Associate Chief of Staff for Research and Development at the Hines Veterans Affairs Hospital and Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois. He is an infectious diseases specialist and hospital epidemiologist, past president of the Society for Healthcare Epidemiology of America and past chair the antibiotic resistance committee of SHEA. He is a fellow of the Infectious Diseases Society of America and past Chair of the National and Global Public Health Committee and the Antibiotic Resistance Subcommittee of IDSA. He served as a member of the Board of Directors of IDSA from 2005-2008. He is a fellow of the American College of Physicians and a member of the American Society for Microbiology.
His research interests include the epidemiology and prevention of Clostridium difficile disease, antimicrobial resistance, and antimicrobial distribution and kinetics. He has been a Merit Review funded research investigator in the VA for over 30 years and is the author of over 300 peer-reviewed journal publications, book chapters, and review articles. He holds patents for the use of non-toxigenic C. difficile for the prevention and treatment of this disease. He is a member of the editorial boards of Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, and Infection Control and Hospital Epidemiology, and is an ad hoc reviewer for numerous other medical journals.



Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.